Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH logo National Institutes of Health

Clinical and Translational Science Awards (CTSA) Program

Creative rendition of SARS-CoV-2 virus particles.
CTSA Program Will Play Key Role in ACTIV-6 Clinical Trial to Study Repurposed Drugs for COVID-19 Symptom Relief

As part of NIH’s ACTIV partnership, NCATS’ CTSA Program is helping to implement a large clinical trial that will evaluate several existing drugs to treat mild to moderate COVID-19 symptoms at home.

Doctors with patients
CTSA Program Hubs Engaging with Communities to Address the COVID-19 Pandemic

CTSA Program hubs are working hand in hand with community partners on a wide range of initiatives to accelerate the discovery and delivery of COVID-19 treatments and vaccines to those in greatest need.

Work With Us

Do you have questions about applying for NCATS funding through the CTSA Program?

Contact NCATS Clinical and Translational Science Awards Program.

Learn more about the CTSA Program Consortium.

CTSA Program Facts

Download the CTSA Program fact sheet (PDF - 766KB)

View the Funded Activities Under the CTSA Program.

Transforming Clinical & Translational Research

Turning scientific discoveries into clinical advances often is an inefficient process due to insufficient resources and too few specially trained researchers. NCATS’ CTSA Program supports an innovative national network of medical research institutions — called “hubs” — that work together to improve the translational research process to get more treatments to more patients more quickly.

CTSA Program hubs collaborate locally, regionally and nationally, fostering innovation in training and research methodologies. NCATS continues to build on the strong foundation of the CTSA Program to tackle system-wide scientific and operational problems to make the clinical and translational research enterprise more efficient. Learn more about the CTSA Program.